Author: https://www.facebook.com/travelandleisure/
Google just released its Holiday 100 list, and it’s stocked with the best gifts for travelers. Read on to find the 10 best finds from the gift guide, from a cashmere sweater to noise-cancelling headphones and carry-on luggage—starting at $20.Read More
The expanded collaboration between KPMG Middle East and Google Cloud highlights KPMG’s commitment to turning enterprise AI, secure cloud adoption, and digital innovation into practical outcomes.Read More
The opening marks a significant step in Samsung’s ongoing commitment to bringing technology closer to people, enabling visitors to explore Samsung’s latest innovations, experience its range of products firsthand, and discover how these technologies enhance and simplify their everyday lives.Read More
The suite integrates advanced agentic cybersecurity capabilities with market-leading threat intelligence from Google and expert human analysis, enabling organizations to strengthen their security posture, fill skills gaps, and enhance team effectiveness while focusing on core business operations.Read More
The initiative represents a major leap forward in Saudi Arabia’s drive to harness artificial intelligence, advanced data analytics, and population health insights to power its Vision 2030 healthcare transformation.Read More
With the rapid increase in mobile device usage and digital access, the TRB emphasizes that device certification is essential not just for technical compliance, but also for service quality, network security, public health, and overall user protection.Read More
Portfolio integrates mesenchymal stem cells, NK cell therapy and AI diagnostics via global licensing with Yike. Launching in Hong Kong, Singapore and China.Read More
The biopharma industry of Europe can use AI to leverage its vast stores of health data to address key challenges.Read More
— Continued rollout of FemBloc, the breakthrough non-surgical permanent contraceptive solution, expands the Company’s presence in key European Markets — ATLANTA, Nov. 10, 2025 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, today announced a significant initial order valued at approximately $500,000 USD for the commercial launch of FemBloc Permanent BRead More
We spoke to five Australian companies in Vienna seeking collaborators and capital at the BIO Europe partnering conference.Read More